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Abstract  ϰϯ 
Whole genome sequencing (WGS) makes it possible to determine the relatedness of ϰϰ 
bacterial isolates at high resolution, helping to characterise outbreaks. However, for ϰϱ 
Staphylococcus aureus, accumulation of within-host diversity during carriage might limit ϰϲ 
interpretation of sequencing data. ϰϳ 
In this study, we hypothesised the converse: that within-host diversity can in fact be ϰϴ 
exploited to reveal the involvement of long-term carriers (LTCs) in outbreaks. We analysed ϰϵ 
WGS data from 20 historical outbreaks, and applied phylogenetic methods to assess genetic ϱϬ 
relatedness and estimate time to most recent common ancestor (TMRCA). Findings were ϱϭ 
compared with the routine investigation results and epidemiological evidence. ϱϮ 
Outbreaks with epidemiological evidence for an LTC source had a mean estimated TMRCA ϱϯ 
(adjusted for outbreak duration) of 243 days (95% CI 143-343), compared with 55 days (28-ϱϰ 
81) for outbreaks lacking epidemiological evidence for an LTC (p=0.004). A threshold of 156 ϱϱ 
days predicted LTC involvement with a sensitivity of 0.875 and a specificity of 1. ϱϲ 
We also found 6/20 outbreaks included isolates with differing antimicrobial susceptibility ϱϳ 
profiles, however, these had only modestly increased pairwise diversity (mean 17.5 single ϱϴ 
nucleotide variants (SNVs) (95% CI 17.3-17.8) vs 12.7 SNVs (12.5-12.8)) compared with ϱϵ 
isolates with identical antibiograms (p<0.0001). Additionally, for 2 outbreaks, WGS identified ϲϬ 
1 or more isolates which were genetically distinct despite having the outbreak PFGE ϲϭ 
pulsotype. ϲϮ 
Duration-adjusted TMRCA allowed the involvement of LTCs in outbreaks to be identified and ϲϯ 
could be used to decide whether screening for long-term carriage (e.g. in healthcare ϲϰ 
workers) is warranted. Requiring identical antibiograms to trigger investigation could miss ϲϱ 
important contributors to outbreaks. ϲϲ 
 ϲϳ 
  ϲϴ 
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Introduction ϲϵ 
To manage Staphylococcus aureus outbreaks effectively, infection control practitioners need ϳϬ 
to determine the relatedness of isolates from suspected cases. Whole genome sequencing ϳϭ 
(WGS) has shown superior resolution compared with standard typing techniques (spa, ϳϮ 
pulsed field gel electrophoresis (PFGE)) when used for individual outbreaks (1-4), and can ϳϯ 
also provide additional information about resistance, pathogenicity and population structure ϳϰ 
(5-8). However, it has been argued that the accumulation of within-host diversity during S. ϳϱ 
aureus carriage could result in erroneous inferences about transmission. This has been cited ϳϲ 
as a potential weakness in applying sequencing to S. aureus outbreaks, and may lead to ϳϳ 
misinterpretation of genuine transmission routes (1, 9, 10). ϳϴ 
However, rather than within-host diversity being a limitation on sequencing-based outbreak ϳϵ 
investigation, it could in fact be exploited to determine whether a long-term carrier is ϴϬ 
implicated in maintaining an outbreak. This information could be used by infection control ϴϭ 
practitioners when considering whether or not to deploy extended screening (e.g. of ϴϮ 
healthcare workers). ϴϯ 
In this study, we tested the hypothesis that WGS can be used to predict the presence of a ϴϰ 
long-term carrier as an outbreak source. First, we examined individuals with newly acquired ϴϱ 
S. aureus nasal carriage to ascertain whether diversity is present at acquisition or develops ϴϲ 
over time. Next, we analysed 20 S. aureus outbreaks, previously investigated using standard ϴϳ 
typing techniques, to assess the added utility of WGS. Finally, we compared WGS with ϴϴ 
epidemiological data to determine whether the presence of a long-term carrier maintaining ϴϵ 
the outbreak could be inferred from the WGS data. ϵϬ 
 ϵϭ 
Results ϵϮ 
Comparison of within-host diversity in newly-acquired and long-term carriage ϵϯ 
Eight subjects were identified with ≥3 consecutive bi-monthly negative nasal swabs, followed ϵϰ 
by ≥1 year of swabs consistently positive for S. aureus. All isolates were MSSA, ϵϱ 
 o
n
 M
ay 10, 2017 by UNIV O
F SUSSEX
http://jcm.asm.org/
D
ow
nloaded from
 
ϰ 
 
representing 7 spa-types, 5 sequence-types and 4 clonal complexes. Median time from first ϵϲ 
to last positive sample was 490 days (range 358-727). In total, 135 isolates were ϵϳ 
successfully sequenced from 16 samples. One isolate (case 1219, early sample) failed ϵϴ 
quality checks and was excluded. ϵϵ 
 ϭϬϬ 
In 6/8 subjects, there was a significant increase in mean pairwise diversity (MPWD) between ϭϬϭ 
the first and last samples (p<0.05; figure 1). In one participant (1236) the increase was not ϭϬϮ 
significant (p=0.52), and for one (1375), there was a decrease which was marginally ϭϬϯ 
significant (p=0.07). Overall, MPWD increased from 0.88 single nucleotide variants (SNVs) ϭϬϰ 
(95%CI 0.65-1.11) to 3.30 (2.92-3.68) between first and last samples (p<0.001). Analysis of ϭϬϱ 
the phylogenetic trees (see supplementary data) showed highly clonal early populations, and ϭϬϲ 
in 2 participants only a single strain was observed. One individual (1219) had a more diverse ϭϬϳ 
early sample (MPWD 4.57, 95%CI 3.10-6.04) compared with the other participants. This ϭϬϴ 
subject’s first positive swab was at month 12, and they had completed a course of co-ϭϬϵ 
amoxiclav one day before their final negative swab. It is therefore possible that this was a ϭϭϬ 
false negative due to antibiotic suppression, meaning that there may have been up to four ϭϭϭ 
months of carriage prior to the first positive swab, accounting for the increased diversity. ϭϭϮ 
 ϭϭϯ 
Two participants (1218 and 1219) shared the same address, and had isolates of the same ϭϭϰ 
spa-type. Participant 1219 (donor) became positive two months before participant 1218 ϭϭϱ 
(recipient). On direct comparison of both early populations, we found that the recipient had ϭϭϲ 
an entirely clonal initial population, identical to 4/8 of the donor’s strains (supplementary ϭϭϳ 
data). ϭϭϴ 
 ϭϭϵ 
For an additional 13 participants positive at study entry, within-host diversity as measured by ϭϮϬ 
MPWD ranged from 0 SNVs (3 individuals) to 26 SNVs. This may be due to differences in ϭϮϭ 
acquisition time to time of first sample, which is unknown for these individuals. ϭϮϮ 
 ϭϮϯ 
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Outbreak characteristics ϭϮϰ 
Twenty outbreaks were included in the study (table 1). Fourteen (70%) were hospital-ϭϮϱ 
associated: 5 neonatal units, 4 general wards, 1 surgical unit, 2 maternity units, and 2 ϭϮϲ 
involved multiple wards or hospital sites. Six (30%) were community-associated: 4 ϭϮϳ 
households, 1 nursing home and 1 school. Reasons for instigating an outbreak investigation ϭϮϴ 
were: increase in MRSA carriage (8 outbreaks); Panton-Valentine Leukocidin (PVL)-ϭϮϵ 
producing skin/soft tissue infection (7 outbreaks); surgical site infections (3 outbreaks); ϭϯϬ 
MRSA bacteraemia (1 outbreak) and staphylococcal scalded skin syndrome (1 outbreak). ϭϯϭ 
Three (15%) were due to MSSA, and 17 (85%) to MRSA. The median number of outbreak ϭϯϮ 
cases was 7 (IQR 5-9). Median duration was 72 days (IQR 44-188). ϭϯϯ 
 ϭϯϰ 
Overall, isolates from 391 cases were sequenced. Nine (2.3%) were from health care ϭϯϱ 
workers (HCWs), the remainder being from patients or household members. Outbreak ϭϯϲ 
samples represented 9 clonal complexes, 11 sequence-types and 12 spa-types. ϭϯϳ 
 ϭϯϴ 
Phylogenetic analysis of outbreaks ϭϯϵ 
Phylogenetic trees for each outbreak are provided in the supplementary data. Two outbreaks ϭϰϬ 
had isolates which were equally or more distant than comparator isolates, despite having the ϭϰϭ 
outbreak pulsotype: outbreak D (one isolate 53 SNVs from index case compared with 21) ϭϰϮ 
and outbreak S (two isolates 49 and 46 SNVs from index case compared with 46). These ϭϰϯ 
were therefore considered to be sporadic, non-outbreak isolates, and were excluded from ϭϰϰ 
further analysis.  ϭϰϱ 
 ϭϰϲ 
The overall MPWD across all outbreak sample pairs for the remaining 388 isolates was 13.8 ϭϰϳ 
SNVs (95%CI 13.6-13.9), compared with 4444 SNVs for non-outbreak spa-matched pairs ϭϰϴ 
(95%CI 2492-6395) and 30192 SNVs for non-outbreak isolates from the same units (95%CI ϭϰϵ 
29781-30603). All outbreak isolates were ≤30 SNVs from the index case. 381/388 (98%) ϭϱϬ 
were ≤10 SNVs from their nearest neighbour. The 7 more distant isolates came from ϭϱϭ 
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outbreaks lasting more than 6 months (B, G and S). All isolates were mapped to a standard ϭϱϮ 
reference genome: mapping to an alternative reference strain (performed for 6 outbreaks) ϭϱϯ 
yielded only 2 additional SNVs overall (see supplementary data), with no effect on topology. ϭϱϰ 
 ϭϱϱ 
Time to most recent common ancestor (TMRCA) and long-term carriers ϭϱϲ 
Twelve outbreaks (60%) had epidemiological evidence of a long-term carrier (LTC): 3 ϭϱϳ 
included cases with recurrent staphylococcal disease, in 5 an LTC was suspected due to ϭϱϴ 
non-overlapping ward stays, and in 4, at least one case had post-outbreak long-term ϭϱϵ 
carriage (figure 2). The pairwise distances between isolates from outbreaks with evidence ϭϲϬ 
for an LTC ranged from 0 to 46 SNVs, compared with 0 to 10 SNVs for outbreaks with no ϭϲϭ 
evidence for an LTC (table 2). Mean duration-adjusted TMRCA for outbreaks with a ϭϲϮ 
suspected or proven LTC was 243 days (95% CI 143-343) compared with 55 days (28-81) ϭϲϯ 
for outbreaks with no evidence for an LTC (p=0.004, figure 2).  Excluding post-outbreak ϭϲϰ 
carriage, analysis of the receiver-operating-characteristic curve gave an AUC of 0.953 (95% ϭϲϱ 
CI 0.851-1). Using the Youden index to select the optimal threshold gave a cut-off value of ϭϲϲ 
156 days, with a sensitivity of 0.875 and a specificity of 1. ϭϲϳ 
 ϭϲϴ 
Relationship between PFGE pulsotype / antibiogram and SNV distance ϭϲϵ 
Five outbreaks contained isolates differing by ≥1 band from the index case on PFGE. MPWD ϭϳϬ 
between outbreak isolates with identical PFGE pulsotypes was 13.6 SNVs (13.4-13.7), ϭϳϭ 
compared with 17.3 (17.0-17.6) between isolates with differing pulsotypes (p<0.0001).  ϭϳϮ 
 ϭϳϯ 
In 6/20 outbreaks, antimicrobial susceptibility differed across isolates, confirmed by the ϭϳϰ 
presence / absence of mobile resistance determinants identified using BLAST, however, ϭϳϱ 
these clearly belonged to the outbreak on phylogenetic analysis. MPWD between isolates ϭϳϲ 
sharing an antibiogram was 12.7 SNVs (95% CI 12.5-12.8) compared with 17.5 (17.3-17.8) ϭϳϳ 
for isolates with differing antibiograms (p<0.0001), although a substantial number of isolate ϭϳϴ 
pairs with different antibiograms had 0 SNVs between their core genomes (figure 4).  ϭϳϵ 
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 ϭϴϬ 
For other factors potentially related to outbreak diversity, there was no evidence of ϭϴϭ 
association between MPWD and any of: outbreak duration, reason for investigation, ϭϴϮ 
epidemiological setting or MRSA phenotype (p>0.05). ϭϴϯ 
 ϭϴϰ 
Discussion ϭϴϱ 
We have tested the use of WGS for S. aureus outbreak investigation using 20 outbreaks. By ϭϴϲ 
comparing observed outbreak SNV distances with non-outbreak and spa/MLST specific ϭϴϳ 
diversity, we were able to distinguish outbreak from non-outbreak strains. ϭϴϴ 
 ϭϴϵ 
Our observation of minimal diversity in recent acquisition of nasal carriage is reassuring for ϭϵϬ 
the application of WGS data to outbreaks. For the donor-recipient pair, we observed a ϭϵϭ 
narrow transmission bottleneck, with a clonal founding population despite a diverse donor ϭϵϮ 
population. Although this is a single case, the findings are supported by the minimal diversity ϭϵϯ 
seen in the early samples for the majority of carriage study subjects, and further evidence for ϭϵϰ 
a narrow transmission bottleneck is provided by the relatively short SNV distances observed ϭϵϱ 
across the outbreaks. Taken together, these findings suggest that, in an acute short term ϭϵϲ 
outbreak, there will be insufficient time for diversity to accumulate.  ϭϵϳ 
 ϭϵϴ 
If WGS is to be used routinely for outbreak investigation, these findings provide evidence ϭϵϵ 
that single colony sequencing is likely to identify clusters reliably in this context, allowing ϮϬϬ 
ease of interpretation and ensuring that WGS remains an affordable alternative to standard ϮϬϭ 
typing, as a requirement for sequencing multiple colonies per case, as implied by previous ϮϬϮ 
investigators (1, 10), would rapidly escalate costs and render WGS too expensive for routine ϮϬϯ 
use. ϮϬϰ 
 ϮϬϱ 
Previous carriage studies have found greater distances than seen here (9, 11), however, ϮϬϲ 
these did not account for estimated time of acquisition. We postulate that the existence of a ϮϬϳ 
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significant cloud of diversity (4, 12) may be a marker of long-term carriage, and therefore, in ϮϬϴ 
outbreaks, higher diversity may indicate the involvement of an LTC, with outbreak diversity ϮϬϵ 
reflecting the donor cloud.  ϮϭϬ 
 Ϯϭϭ 
In support of this, we observed a significant difference in duration-adjusted TMRCA between ϮϭϮ 
outbreaks with and without evidence of an LTC. The longest TMRCAs were in hospital Ϯϭϯ 
outbreaks with indirect links between cases (i.e. non-overlapping ward stays). The likelihood Ϯϭϰ 
of “missed” cases in these outbreaks was considered low due to enhanced screening, and Ϯϭϱ 
the most likely reason for the reoccurrence of the outbreak strain was thought by the Ϯϭϲ 
investigating teams to be either re-introduction from the community (outbreak G) or a staff Ϯϭϳ 
member with long-term carriage (outbreaks A, I, N and S). Staff carriage was proven in one Ϯϭϴ 
outbreak (by sampling and subsequent termination of the outbreak on their exclusion), but in Ϯϭϵ 
the remaining outbreaks HCWs were either not sampled, or HCW sampling was anonymised ϮϮϬ 
and positive results could not be linked definitively with the suspected carrier. ϮϮϭ 
 ϮϮϮ 
The study necessarily reflects the circulating S. aureus clones in the UK and the concerns of ϮϮϯ 
local infection control teams. The sampling frame is therefore enriched for MRSA and PVL-ϮϮϰ 
positive outbreaks and neonatal unit; despite this there is a wide representation of sequence ϮϮϱ 
types.  ϮϮϲ 
 ϮϮϳ 
Despite the enhanced surveillance during each outbreak, there are inevitably missing ϮϮϴ 
transmission links, due to missed sampling, suppression from antimicrobial therapy, or ϮϮϵ 
delays in identifying contacts.  One reason for missed samples may be the use of ϮϯϬ 
antibiograms as an initial screening tool for identifying putative outbreak isolates, as most Ϯϯϭ 
investigating teams only collected isolates with identical or highly similar antimicrobial ϮϯϮ 
susceptibility profiles. However, in the six outbreaks where isolates were included with Ϯϯϯ 
differing antibiograms, the core genomes were remarkably conserved. This is presumably Ϯϯϰ 
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due to the ready loss/gain of mobile genetic elements (13), and shows that reliance on Ϯϯϱ 
antibiograms may lead to samples being wrongly excluded. Ϯϯϲ 
 Ϯϯϳ 
The variability of mobile elements is also important for interpreting genetic distances. Ϯϯϴ 
Recombination events such as gain/loss of a mobile element will introduce a large number of Ϯϯϵ 
SNVs even though this represents a single genetic event. Current analysis tools which can ϮϰϬ 
accommodate this are computationally complex and, for large datasets, require sizable Ϯϰϭ 
computing resources. A simpler approach is to exclude the “mobile-ome” from phylogenetic ϮϰϮ 
analyses and compare only the core genome, and the results above demonstrate that this is Ϯϰϯ 
an acceptable strategy. Similarly, mapping to alternative reference strains (performed for six Ϯϰϰ 
outbreaks) had minimal effect on SNV analysis and phylogeny, removing the need for Ϯϰϱ 
identification of clonal complex or index case assembly prior to phylogenetic analysis. This Ϯϰϲ 
streamlined approach brings WGS closer to routine use, as a readily deployable method with Ϯϰϳ 
a minimal burden of computational time and bioinformatic expertise. Ϯϰϴ 
 Ϯϰϵ 
In conclusion, we have demonstrated how a WGS-based approach can be applied to S. ϮϱϬ 
aureus outbreak investigations. We have shown that current sampling strategies provide Ϯϱϭ 
sufficient information to determine whether isolates belong to an outbreak, and that, rather ϮϱϮ 
than confounding the investigation, within-host diversity can be utilised to identify the Ϯϱϯ 
possible involvement of a long-term carrier, potentially enhancing the infection control Ϯϱϰ 
response. Combining this with directed multi-sampling of suspected LTCs (1) may be a cost-Ϯϱϱ 
effective method of using WGS to ensure that, where HCWs are implicated, potentially Ϯϱϲ 
career altering decisions are made using the best possible evidence. Ϯϱϳ 
 Ϯϱϴ 
Methods Ϯϱϵ 
Comparison of within-host diversity in newly acquired and long-term carriage ϮϲϬ 
Eight participants were identified from a population study of S. aureus nasal carriage in Ϯϲϭ 
adults attending general practices in Oxfordshire (14), in which participants had nasal swabs ϮϲϮ 
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taken at two-monthly intervals, with positive samples stored as mixed glycerol stocks taken Ϯϲϯ 
by sweeping across multiple colonies on the primary plates to preserve the diversity of Ϯϲϰ 
carried strains (11). The eight participants were negative for nasal carriage at recruitment Ϯϲϱ 
and had consistently negative swabs for ≥6 months subsequently, before acquiring a strain Ϯϲϲ 
which they carried for at least one year. The first and last positive samples for each Ϯϲϳ 
individual were retrieved from the mixed glycerol stocks. Samples were plated on Columbia Ϯϲϴ 
blood agar (CBA) and incubated overnight at 37ºC. For each time-point, 8 individual colonies Ϯϲϵ 
(12 for one individual, id=1218) were selected and sub-cultured to a further CBA plate and ϮϳϬ 
again incubated overnight at 37ºC.  Ϯϳϭ 
 ϮϳϮ 
We also retrieved sequencing data from 13 participants previously investigated, for whom Ϯϳϯ 
the approximate time of acquisition was unknown (9). Each of these had 8-12 individual Ϯϳϰ 
colonies sequenced. Ϯϳϱ 
 Ϯϳϲ 
Collection of outbreak isolates and epidemiological data Ϯϳϳ 
19 outbreaks were purposively sampled in collaboration with the Public Health England Ϯϳϴ 
(PHE) reference laboratory, representing a range of sequence-types and epidemiological Ϯϳϵ 
settings, and including both MRSA and MSSA. One further outbreak was investigated in ϮϴϬ 
conjunction with Lausanne University Hospital, Switzerland (15, 16). Epidemiological Ϯϴϭ 
information was obtained from each infection control team (specimen date, site, ward ϮϴϮ 
location and, where applicable, admission/discharge dates and previous screening results). Ϯϴϯ 
 Ϯϴϰ 
For each outbreak, additional background isolates were also included for comparison. We Ϯϴϱ 
sequenced all isolates submitted to PHE as part of the outbreak investigation, including Ϯϴϲ 
those identified as “non-outbreak” by routine typing, to estimate expected genetic diversity Ϯϴϳ 
outwith the outbreak strain, and to ensure that the apparent outbreak strains were not part of Ϯϴϴ 
an ongoing clonal expansion. We also included non-epidemiologically linked isolates Ϯϴϵ 
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matched for spa-type and/or MLST, to provide a comparison for expected within-spa ϮϵϬ 
distances, and to provide an outgroup for phylogenetic analysis. Ϯϵϭ 
 ϮϵϮ 
Isolates were retrieved from single colony frozen stocks held at the PHE reference Ϯϵϯ 
laboratory, Colindale, London, or at Lausanne University Hospital. We used only the first Ϯϵϰ 
isolate from each case, and included isolates both from clinical samples and screening Ϯϵϱ 
swabs. Ϯϵϲ 
 Ϯϵϳ 
Extraction and sequencing Ϯϵϴ 
DNA was extracted and sequenced as previously described (6) from a single colony sub-Ϯϵϵ 
cultured on CBA and incubated for 18-24hrs. Sequencing was performed using the Illumina ϯϬϬ 
HiSeq or MiSeq platforms. ϯϬϭ 
  ϯϬϮ 
Genome assembly and construction of phylogenetic trees ϯϬϯ 
For all outbreaks, reads were aligned using Stampy v1.0.17 to a standard reference genome ϯϬϰ 
(MRSA252: GenBank NC_002952) (17). Six outbreaks were also mapped to clonal-complex ϯϬϱ 
specific reference genomes obtained from in-house collections or GenBank. Single ϯϬϲ 
nucleotide variants were identified across all mapped non-repetitive sites using SAMtools v ϯϬϳ 
0.1.18 mpileup, with the extended base‐alignment quality flag and masking of mobile genetic ϯϬϴ 
elements. A consensus of ≥75%, and ≥5 reads, including one in each direction, was required ϯϬϵ 
to support a SNV, and calls were required to be homozygous under a diploid model. ϯϭϬ 
Maximum likelihood trees were estimated from the mapped whole genomes using PhyML ϯϭϭ 
(18).  ϯϭϮ 
 ϯϭϯ 
Outbreak analysis and calculation of TMRCA ϯϭϰ 
The index case was defined as the earliest microbiologically confirmed case in each cluster. ϯϭϱ 
Outbreak cases were defined as those sharing related PFGE pulsotypes (19) plus a definite ϯϭϲ 
epidemiological link to the index or secondary cases (>24hr stay in same ward, or ϯϭϳ 
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ϭϮ 
 
household/classroom/similar community situation with prolonged contact e.g. childcare). For ϯϭϴ 
each outbreak case, the genetic distance in SNVs was calculated from the index case and ϯϭϵ 
the next nearest neighbour. If an isolate was more distant from the index case than the ϯϮϬ 
nearest spa/MLST-matched comparator, it was considered sporadic and excluded from ϯϮϭ 
further outbreak analysis. ϯϮϮ 
 ϯϮϯ 
We classified each outbreak according to the possibility of long-term carrier involvement ϯϮϰ 
(LTC, carrying for ≥6 weeks) as follows: ϯϮϱ 
 ϯϮϲ 
1) LTC not suspected: direct contact between cases, no history of pre-existing ϯϮϳ 
staphylococcal disease ϯϮϴ 
2) evidence for a pre- or peri-outbreak LTC: either ≥1 case with prior history of recurrent ϯϮϵ 
staphylococcal disease, or non-overlapping hospital stays (ward case identified after a case-ϯϯϬ 
free interval, indicating a possible healthcare-worker carrier) ϯϯϭ 
3) evidence of a post-outbreak LTC: ≥1 case with positive nasal swab >6 weeks after initial ϯϯϮ 
swab (indicating a propensity for long term carriage). ϯϯϯ 
 ϯϯϰ 
To evaluate the relationship between outbreak diversity and the likelihood of a long term ϯϯϱ 
carrier, we estimated time to most recent common ancestor (TMRCA) using BEAST v1.8.1 ϯϯϲ 
(20). We applied a simple HKY substitution model with constant population size and a ϯϯϳ 
standardized substitution rate of 3.3x10-6 substitutions per genome per year (7) (see ϯϯϴ 
supplementary data). To control for differences in outbreak duration, outbreaks were ϯϯϵ 
censored at six months, and the (censored) outbreak duration subtracted from the calculated ϯϰϬ 
TMRCA to obtain a duration-adjusted TMRCA. ϯϰϭ 
 ϯϰϮ 
We compared SNV distances between isolates of identical pulsotype and those differing by ϯϰϯ 
one or more band. To determine whether there was an increase in genetic diversity ϯϰϰ 
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ϭϯ 
 
associated with acquisition of antimicrobial resistance, we also interrogated the predicted ϯϰϱ 
antibiograms as previously described (21).  ϯϰϲ 
 ϯϰϳ 
Statistical analyses were performed using Stata v13.1. Mean pairwise differences were ϯϰϴ 
modelled using normal linear regression using robust standard errors to account for ϯϰϵ 
dependence within person/outbreak. The ability of TMRCA to differentiate between ϯϱϬ 
outbreaks with evidence for an LTC compared with outbreaks with no evidence for an LTC ϯϱϭ 
was evaluated using a receiver-operating-characteristic curve analysis. ϯϱϮ 
 ϯϱϯ 
The sequences reported in this paper have been deposited in the NCBI Sequence Read ϯϱϰ 
Archive under bioproject number PRJNA380544. ϯϱϱ 
 ϯϱϲ 
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Tables and Figures ϰϲϬ 
Taďle ϭ. DesĐƌiptioŶ of ϮϬ outďƌeaks aŶalǇsed ďǇ ǁhole geŶoŵe seƋueŶĐiŶg ϰϲϭ 
Outbreak Epidemiological category 
No of 
cases 
Reason for outbreak 
investigation 
MRSA 
or 
MSSA 
Clonal 
complex MLST spa 
Duration 
(days) 
PFGE 
pulsotypes 
Outbreak 
antibiograms 
A Hospital - general ward 5 MRSA colonisation MRSA CC22 ST22 t032 367 All identical All identical 
B Hospital - general ward 6 S. aureus wound infections MSSA CC8 ST2021 t008 412 All identical All identical 
C Hospital - general ward 7 S. aureus wound infections MRSA CC8 ST239 t037 98 All identical All identical 
D Hospital - general ward 17 MRSA colonisation MRSA CC8 ST8 t008 88 All identical All identical 
E Hospital – surgical unit 8 S. aureus wound infections MRSA CC22 ST22 t022 18 All identical All identical 
F Hospital - multiple wards 50 MRSA colonisation MRSA CC5 ST228 t041 122 2 pulsotypes All identical 
G Hospital - multiple wards 187 MRSA colonisation MRSA CC8 ST8 t008 454 4 pulsotypes 3 antibiograms 
H Hospital - maternity unit 6 PVL-related SSTIs MRSA CC1 ST772 t657 70 All identical All identical 
I Hospital - maternity unit 9 Scalded skin syndrome MSSA CC15 ST2434 t346 70 All identical 2 antibiograms 
J Hospital - neonatal unit 3 MRSA colonisation MRSA CC59 ST59 t216 8 All identical All identical 
K Hospital - neonatal unit 4 MRSA colonisation MRSA CC22 ST22 t5892 43 All identical All identical 
L Hospital - neonatal unit 6 MRSA colonisation MRSA CC30 ST30 t019 57 All identical All identical 
M Hospital - neonatal unit 8 MRSA bacteraemia MRSA CC88 ST88 t5973 65 All identical 3 antibiograms 
N Hospital - neonatal unit 41 MRSA colonisation MRSA CC22 ST22 t5892 1526 All identical 2 antibiograms 
O Household 3 PVL-related SSTIs MRSA CC30 ST30 t019 8 All identical All identical 
P Household 4 PVL-related SSTIs  MRSA CC30 ST30 t019 20 3 pulsotypes All identical 
Q Household 5 PVL-related SSTIs  MRSA CC30 ST30 t019 195 2 pulsotype All identical 
R Household 8 PVL-related SSTIs  MRSA CC30 ST30 t019 44 All identical 2 antibiograms 
S Nursing home 9 PVL-related SSTIs  MRSA CC30 ST30 t019 298 2 pulsotypes 3 antibiograms 
T School 5 PVL-related SSTIs  MSSA CC121 ST121 t645 74 All identical All identical 
PVL: Panton-Valentine Leukocidin; MLST: multi-locus sequence-typeϰϲϮ 
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Figure 1. All pairwise differences between early (<2 months since acquisition) and late (>12 ϰϲϯ 
months since acquisition) nasal swab samples from 7 patients with previous negative nasal ϰϲϰ 
swabs. Included for comparison are samples from patients positive at entry to the study ϰϲϱ 
(time of acquisition unknown). ϰϲϲ 
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Taďle Ϯ: LoŶg teƌŵ Đaƌƌieƌ ĐategoƌǇ, duƌatioŶ-adjusted TMRCA aŶd SNV ƌaŶge foƌ outďƌeaks ϰϳϬ 
iŶǀestigated usiŶg WGS ϰϳϭ 
Outďreak LoŶg terŵ Đarrier Đategory 
DuratioŶ- adjusted 
TMRCA, days ;95% highest 
posterior deŶsity iŶterǀalͿ 
RaŶge of distaŶĐes 
ďetǁeeŶ all isolates 
iŶ Đluster, SNVs 
A IŶdiƌeĐt ǁaƌd ĐoŶtaĐt Ϯϴϱ ;ϭϯϰ-ϰϰϱͿ Ϭ-ϭϵ 
B IŶdiƌeĐt ǁaƌd ĐoŶtaĐt ϱϭϱ ;ϯϵϰ-ϲϰϲͿ Ϭ-Ϯϰ 
C DiƌeĐt ǁaƌd ĐoŶtaĐt ϭϬϯ ;ϲϭ-ϮϮϴͿ Ϭ-ϵ 
D DiƌeĐt ǁaƌd ĐoŶtaĐt ϳϴ ;Ϯϭ-ϭϱϯͿ Ϭ-ϭϬ 
E Post outďƌeak LTC ϵϲ ;ϰϬ-ϭϲϱͿ Ϭ-ϲ 
F DiƌeĐt ǁaƌd ĐoŶtaĐt ϴϲ ;ϯϲ-ϭϲϬͿ Ϭ-ϱ 
G IŶdiƌeĐt ǁaƌd ĐoŶtaĐt ϯϵϰ ;Ϯϱϵ-ϱϯϵͿ Ϭ-ϰϲ 
H DiƌeĐt ǁaƌd ĐoŶtaĐt ϰϲ ;ϱ-ϵϱͿ Ϭ-ϰ 
I Post outďƌeak LTC ϯϬ ;ϭ-ϲϵͿ Ϭ-ϱ 
J Post outďƌeak LTC ϭϲϭ ;ϲϭ-ϮϳϭͿ Ϭ-ϵ 
K DiƌeĐt ǁaƌd ĐoŶtaĐt ϯϭ ;Ϭ-ϴϮͿ ϭ-ϰ 
L Post outďƌeak LTC Ϯϭϲ ;ϭϯϰ-ϯϭϰͿ Ϭ-ϴ 
M DiƌeĐt ǁaƌd ĐoŶtaĐt ϱϰ ;ϵ-ϭϬϳͿ Ϭ-ϰ 
N IŶdiƌeĐt ǁaƌd ĐoŶtaĐt ϭϱϲ ;ϱϬ-ϮϳϱͿ Ϭ-ϯϲ 
O Pƌe-outďƌeak LTC ϯϳϴ ;ϮϰϬ-ϱϯϭͿ ϵ-Ϯϱ 
P Pƌe-outďƌeak LTC ϱϰ ;ϭϮ-ϭϮϰͿ ϭ-ϭϭ 
Q Pƌe-outďƌeak LTC ϮϬϰ ;ϭϬϴ-ϯϬϲͿ ϭ-ϭϯ 
R Household Ϯϵ ;Ϭ-ϳϯͿ ϭ-Ϯ 
S IŶdiƌeĐt ǁaƌd ĐoŶtaĐt ϰϯϭ ;Ϯϲϵ-ϱϵϵͿ ϯ-ϯϮ 
T SĐhool ϭϮ ;Ϭ-ϰϬͿ Ϭ-Ϯ 
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Figure 2. Duration-adjusted TMRCA for outbreaks with 1) no evidence of a long term carrier (direct ϰϳϰ 
contacts between all cases); 2) likely LTC (indirect ward contacts or pre-outbreak LTC); 3) LTC ϰϳϱ 
unclear / possible (evidence of a post-outbreak LTC) ϰϳϲ 
 ϰϳϳ 
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Figure 3. Pairwise SNV diffences for all pairs within an outbreak, where isolates had differing antibiograms (a) or differing PFGE pulsotypes (b) ϰϴϬ 
ϰϴϭ 
aͿ ďͿ 
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